Because MAP kinases are activator signals for lung fibroblasts [23], we suggest that cytohesin-2 might participate in the development and/or progression of lung fibrosis in SSc patients through the activation of the MAP kinase signaling pathways in lung fibroblasts. This evidence concerns the gene CYTH2 and pulmonary fibrosis.